Search Results 561-570 of 17262 for GLP-1 therapy

1. Transcriptomic Changes Before And After Anti-tnf Therapy Utilizing Optimum Therapeutic Drug Levels - Mayo Clinic

   Eligibility last updated 1/27/2025. Questions regarding updates should be directed to the study team contact. Participating Mayo Clinic locations. Study ...

2. Pharmacokinetics and Pharmacodynamic Biomarkers of Janus Kinase Inhibitor Therapy in Patients with Ulcerative Colitis (PROPHETIC Study) - Mayo Clinic

   ... treatment works better than the current standard therapy. ... 1 trial. Phase 4 trials look at long-term safety ... Interval between live vaccinations and initiation ...

3. Clinical trials - Oncology (Medical)

   ... therapy without inotuzumab ozogamicin. Inotuzumab ... Patients will be randomized 1:1 into the two arms. ... treatment in patients with treatment-naive ...

4. Phase 1/2 Study of TP-0903 (an Inhibitor of AXL Kinase) in Patients With Previously Treated CLL - Mayo Clinic

   AXL was identified as a potential therapeutic target in chronic lymphocytic leukemia (CLL). TP 0903 was shown to induce apoptosis in CLL B-cells taken directly ...

5. CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study - Mayo Clinic

   About this study. The primary endpoint is to assess the safety and tolerability of CD-NP with the incidence of symptomatic hypotension being one of the key ...

6. Arteriovenous fistula - Doctors and departments - Mayo Clinic

   Had to reduce blood pressure meds due to GLP-1. Anyone else? 2 Replies Fri, Dec 05, 2025. See more discussions. Related. Associated Procedures. CT scan ...

7. Immune globulin-ifas (intravenous route) - Side effects & uses - Mayo Clinic

   If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Adenovirus Vaccine Type 4, Live ...

8. Study of an Experimental Antisense Oligonucleotide Treatment for a Patient With LMNB1 Mutation Associated Autosomal Dominant Leukodystrophy (ADLD) - Mayo Clinic

   Currently there is no standard therapy for LMNB1 mutation associated Autosomal Dominant Leukodystrophy (ADLD), a fatal central nervous system white matter ...

9. Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) - Mayo Clinic

   ... 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market. Study IDs. Site IRB.

10. An Open-Label Study Of XOMA 358 In Patients With Hypoglycemia After Gastric Bypass Surgery - Mayo Clinic

    ... treatment works better than the current standard therapy. They also compare ... therapy, sulfonylureas, SGLT2 inhibitors, and GLP-1 agonists; Systemic ...